<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 2</label>
  <p class="p" xmlns="">The fatty acids existing in fish oils for preventing or treating cutaneous carcinogenesis.</p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Composition</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Experimental Model</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Tumor-Induced Approach</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Benefit</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Reference</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA and EPA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Keratinocytes HaCaT</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Growth factors in 3% FBS</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Induced pre-malignant keratinocyte apoptosis</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Nikolakopoulou et al. [ 
    <xref rid="B66-marinedrugs-16-00256" ref-type="bibr" class="xref">66</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Melanoma A-375</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Standard culture medium</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Synergistic growth inhibition combined with NSAIDs</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Chiu et al. [ 
    <xref rid="B67-marinedrugs-16-00256" ref-type="bibr" class="xref">67</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil, DHA, and EPA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">BCC TE 354 and SCC A431</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Standard culture medium</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Synergistic growth inhibition combined with imiquimod</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Rehman et al. [ 
    <xref rid="B70-marinedrugs-16-00256" ref-type="bibr" class="xref">70</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss albino mouse</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DMBA-induced papilloma</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced tumor size and enhanced IL-10</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Rehman and Zulfakar [ 
    <xref rid="B71-marinedrugs-16-00256" ref-type="bibr" class="xref">71</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss albino mouse</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Benzo(a)pyrene and croton oil</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced papilloma number per mouse</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Ramesh and Das [ 
    <xref rid="B74-marinedrugs-16-00256" ref-type="bibr" class="xref">74</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hairless mouse</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">UV 280–320 nm, 30 mJ/cm 
    <sup class="sup">2</sup>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced size of papilloma, keratoacanthoma, and carcinoma</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Lou et al. [ 
    <xref rid="B75-marinedrugs-16-00256" ref-type="bibr" class="xref">75</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Omega-3 and omega-6 fatty acids</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SCC patients</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Lower SCC risk with the higher omega-3/omega-6 intake</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hakim et al. [ 
    <xref rid="B76-marinedrugs-16-00256" ref-type="bibr" class="xref">76</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fish oil rich in omega-3 PUFAs</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Melanoma patients</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Lower melanoma risk with the fish oil intake</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Fortes et al. [ 
    <xref rid="B77-marinedrugs-16-00256" ref-type="bibr" class="xref">77</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DNA-paclitaxel conjugate</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Melanoma patients</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Prolonged median survival period</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Homsi et al. [ 
    <xref rid="B78-marinedrugs-16-00256" ref-type="bibr" class="xref">78</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Conjugated LA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mouse</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DMBA- and TPA-induced tumor</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced PPAR-δ and K-FABP</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Belury et al. [ 
    <xref rid="B81-marinedrugs-16-00256" ref-type="bibr" class="xref">81</xref>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p charset="fn" class="fn">
   <p class="p" xmlns="">BCC, basal cell carcinoma; DMBA, 7,12-dimethylbenz[a]anthracene; FBS, fetal bovine serum; K-FABP, keratinocyte fatty acid binding protein; LA, linoleic acid; NSAIDs, non-steroidal anti-inflammatory drugs; PPAR-δ, peroxisome proliferator-activated receptor; SCC, squamous cell carcinoma; TPA, 12-O-tetradecanoylphorbol-13-acetate.</p>
  </p>
 </tfoot>
</table>
